172 related articles for article (PubMed ID: 16044045)
1. Biocompatibility in vitro tests of mineral trioxide aggregate and regular and white Portland cements.
Ribeiro DA; Duarte MA; Matsumoto MA; Marques ME; Salvadori DM
J Endod; 2005 Aug; 31(8):605-7. PubMed ID: 16044045
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and cytotoxicity of mineral trioxide aggregate and regular and white Portland cements on Chinese hamster ovary (CHO) cells in vitro.
Ribeiro DA; Sugui MM; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):258-61. PubMed ID: 16448930
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo assessment of genotoxicity and cytotoxicity in murine fibroblasts exposed to white MTA or white Portland cement with 15% bismuth oxide.
Zeferino EG; Bueno CE; Oyama LM; Ribeiro DA
Int Endod J; 2010 Oct; 43(10):843-8. PubMed ID: 20722754
[TBL] [Abstract][Full Text] [Related]
4. In vitro biocompatibility tests of two commercial types of mineral trioxide aggregate.
Ribeiro DA; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Braz Oral Res; 2005; 19(3):183-7. PubMed ID: 16308605
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo biocompatibility tests of regular and white forms of mineral trioxide aggregate.
Ribeiro DA; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Int Endod J; 2006 Jan; 39(1):26-30. PubMed ID: 16409325
[TBL] [Abstract][Full Text] [Related]
6. The chemical constitution and biocompatibility of accelerated Portland cement for endodontic use.
Camilleri J; Montesin FE; Di Silvio L; Pitt Ford TR
Int Endod J; 2005 Nov; 38(11):834-42. PubMed ID: 16218977
[TBL] [Abstract][Full Text] [Related]
7. Effect of mineral trioxide aggregates and Portland cements on inflammatory cells.
Shahi S; Rahimi S; Yavari HR; Mokhtari H; Roshangar L; Abasi MM; Sattari S; Abdolrahimi M
J Endod; 2010 May; 36(5):899-903. PubMed ID: 20416442
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of genetic damage in human peripheral lymphocytes exposed to mineral trioxide aggregate and Portland cements.
Braz MG; Camargo EA; Salvadori DM; Marques ME; Ribeiro DA
J Oral Rehabil; 2006 Mar; 33(3):234-9. PubMed ID: 16512891
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of white MTA, MTA Fillapex® and Portland cement on human periodontal ligament fibroblasts.
Yoshino P; Nishiyama CK; Modena KC; Santos CF; Sipert CR
Braz Dent J; 2013; 24(2):111-6. PubMed ID: 23780362
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity and cytotoxicity of mineral trioxide aggregate and calcium enriched mixture cements on L929 mouse fibroblast cells.
Naghavi N; Ghoddusi J; Sadeghnia HR; Asadpour E; Asgary S
Dent Mater J; 2014; 33(1):64-9. PubMed ID: 24492114
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of new MTA-based cement formulations on fibroblast-like MDPL-20 cells.
Garcia Lda F; Santos AD; Moraes JC; Costa CA
Braz Oral Res; 2016; 30():. PubMed ID: 26981755
[TBL] [Abstract][Full Text] [Related]
12. Cell and tissue reactions to mineral trioxide aggregate and Portland cement.
Saidon J; He J; Zhu Q; Safavi K; Spångberg LS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Apr; 95(4):483-9. PubMed ID: 12686935
[TBL] [Abstract][Full Text] [Related]
13. Genotoxicity in primary human peripheral lymphocytes after exposure to regular and white mineral trioxide aggregate.
da Silva GN; Braz MG; de Camargo EA; Salvadori DM; Ribeiro DA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):e50-4. PubMed ID: 17052626
[TBL] [Abstract][Full Text] [Related]
14. Rat subcutaneous tissue response to modified Portland cement, a new mineral trioxide aggregate.
Martínez Lalis R; Esaín ML; Kokubu GA; Willis J; Chaves C; Grana DR
Braz Dent J; 2009; 20(2):112-7. PubMed ID: 19738942
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of White-MTA and MTA-Bio cements on odontoblast-like cells (MDPC-23).
Lessa FC; Aranha AM; Hebling J; Costa CA
Braz Dent J; 2010 Jan; 21(1):24-31. PubMed ID: 20464317
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and genotoxicity of root canal sealers based on mineral trioxide aggregate.
Bin CV; Valera MC; Camargo SE; Rabelo SB; Silva GO; Balducci I; Camargo CH
J Endod; 2012 Apr; 38(4):495-500. PubMed ID: 22414836
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of subcutaneous tissue responses to a novel root-end filling material and white and grey mineral trioxide aggregate.
Parirokh M; Mirsoltani B; Raoof M; Tabrizchi H; Haghdoost AA
Int Endod J; 2011 Apr; 44(4):283-9. PubMed ID: 21091493
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of human osteosarcoma cell line genotoxicity effects of mineral trixoide aggregate and calcium silicate cements.
Ding SJ; Kao CT; Chen CL; Shie MY; Huang TH
J Endod; 2010 Jul; 36(7):1158-62. PubMed ID: 20630290
[TBL] [Abstract][Full Text] [Related]
19. Understanding mineral trioxide aggregate/Portland-cement: a review of literature and background factors.
Steffen R; van Waes H
Eur Arch Paediatr Dent; 2009 Jun; 10(2):93-7. PubMed ID: 19627674
[TBL] [Abstract][Full Text] [Related]
20. Cellular toxicity of mineral trioxide aggregate mixed with an alternative delivery vehicle.
Karimjee CK; Koka S; Rallis DM; Gound TG
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e115-20. PubMed ID: 16997085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]